Mouse neuroblastoma (NB) cells in culture were more sensitive to sodium L-ascorbate than were rat glioma cells by the criterion of growth inhibition (due to cell death and reduction in cell division). Sodium L-ascorbate at nonlethal concentrations potentiated the effect of 5-fluorouracil (FUra), x-irradiation, bleomycin, R020-1724, prostaglandin El, and sodium butyrate on NB cells but did not produce such an effect on glioma cells. Sodium L-ascorbate did not enhance the effect of vincristine, 6-thioguanine, or 1-2-chloroethyl--cyclohexyl-1-nitrosourea (CCNU) except at higher drug doses and it reduced the cytotoxic effect of methotrexate and 5-3,3-dimethyl-1-triazeno)imidazole4-carboxamide (DTIC) on NB cells. Sodium D-ascorbate produced effects similar to those produced by sodium L-asco ate on NB cells. L-Ascorbic acid-2-sulfate (barium salt) affected neither the growth rate nor the effect of 5-FUra on NB cells. Glutathione, a reducing agent, was more toxic to NB cells in comparison to D-or L-ascorbate; however, at a similar concentration it failed to potentiate the effect of 5-FUra on NB cells.
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The beneficial effect of high doses of ascorbic acid in advanced human neoplasms has been reported (1) (2) (3) . Because of its potential significance as a chemotherapeutic agent, the effects of sodium ascorbate in combination with some tumor therapeutic agents were studied to ascertain if sodium ascorbate would potentiate their growth inhibitory effect (due to cell death and reduction of cell division). We report that sodium ascorbate at nonlethal concentrations potentiates the growth inhibitory effect of 5-fluorouracil (5-FUra), bleomycin sulfate, sodium butyrate, cyclic AMP stimulating agents, and x-irradiation on neuroblastoma (NB) cells, but it does not produce a similar effect on rat glioma cells in culture.
MATERIALS AND METHODS
The procedures for culturing and maintaining mouse neuroblastoma (NBP2) cells have been described (4) . Rat glioma (C-6, passage number 24-38) cells developed by Benda et al. (5) , were maintained in Eagle's minimal essential medium containing 10% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 ,g/ml). Mouse fibroblasts (L cells) were grown under conditions described for NB cells. L-Ascorbic acid (Sigma) or D-isoascorbic acid (Sigma) was dissolved in water at a concentration of 10 mg/ml and the pH was adjusted to 7.0 with sodium hydroxide. Sodium ascorbate in solution is unstable (6, 7) and light sensitive; therefore, a fresh solution was made every week, and the vials were wrapped with aluminum foil to protect the solution against light. Beef liver catalase suspended in 0.1% thymol (Sigma) was diluted with water at a concentration of 5 mg/ml. The concentration of the original stock solution was 50 mg/ml (33,300 units/ml). One unit decomposes 1 umol of hydrogen peroxide per min at pH 7.0 at 250C. 5-FUra, 5-(3,3-dimethyl-btriazeno)-imidazole-4-carboxamide (DTIC), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), bleomycin sulfate, adriamycin sulfate, 6-thioguanine, vincristine, sodium butyrate, and methotrexate were dissolved in water. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO20-1724) and prostaglandin E1 were dissolved in 50% ethyl alcohol. All solutions were stored at 4VC. The procedure for x-irradiation has been described (4).
The cells (NB, 50,000 cells; glioma, 100,000 cells) were plated in Falcon plastic dishes (60 mm) and then treated with drugs or x-irradiated 24 hr later. One set of control cultures received an equivalent volume of water or ethyl alcohol (final concentration, 0.5%) and another set received no treatment. The growth rate of cells in all control cultures was similar; therefore, the cell number values of controls were pooled. Drug and medium were changed every day. The percentage of cells stained with trypan blue (0.2% in saline) among attached cell populations was determined.
The cells were removed from the flask surface by incubation in the presence of 0.25% pancreatin. All NB cells detached from the flask surface after 10-15 min of incubation with pancreatin solution, whereas glioma cells required a relatively longer time (30-40 min) in trypsin solution (0.25%). The cells were counted by a Coulter Counter. The number of viable cells was determined by subtracting the number of stained cells from the total number of cells. The classical definition of cell viability based on colony-forming assay may not be applicable to NB cells because many agents (4) transform dividing NB cells to differentiated nondividing cells. These cells do not pick up trypan blue and contain several morphological and biochemical features of mature neurons. Therefore, the effect of various drugs was determined by measuring the number of viable cells per culture dish.
RESULTS
Effect of Ascorbic Acid and Glutathione. Sodium L-ascorbate at 500 ,ug/ml (2.53 mM) produced >99% lethality in NB cells in culture within 48 hr of treatment, whereas glioma cells required a higher concentration for a similar effect (Fig.  1) . Sodium D-isoascorbate was equally effective, but glutathione, another reducing agent, was more toxic to NB cells than was L-or D-ascorbate (Fig. 2) . L-Ascorbic acid-2-sulfate (barium salt) at 200-1000 ,g/ml did not affect the growth rate (Fig. 2 (Fig. 4) . imal effect of the combined treatment of 5-FUra and sodium ascorbate was seen 3 days after treatment (Fig. 5) .
Sodium ascorbate also potentiated the effect of x-irradiation on NB cells (Table 1) . However, at a nonlethal concentration, sodium L-ascorbate enhanced neither the effect of 5-FUra nor the effect of x-irradiation on glioma cells in culture (Table 1) . Sodium L-ascorbate also potentiated the growth inhibitory effect of bleomycin sulfate, R020-1724 (an inhibitor of cyclic nucleotide phosphodiesterase), prostaglandin E1 (a stimulator of adenylate cyclase), and sodium butyrate on NB cells in culture (Table 2) ; however, it did not have such an effect on glioma cells in culture (data not shown). Sodium L-ascorbate did not enhance the growth inhibitory effect of vincristine, 6-thioguanine, or CCNU (Table 3) except at higher drug doses (8) .
Sodium D-ascorbate was effective in enhancing the effect of 5-FUra on NB cells (Table 4) . L-Ascorbate acid-2-sulfate and glutathione at concentrations of 200 and 25 ,ug/ml, respectively, did not potentiate the effect of 5 5 ,ug/ml for NB, 100 ,ug/ml for glioma; 5-FUra, 0.08,g/ml for NB; 0.3,g/ml for glioma or x-irradiation [400 rads (4 grays)] were given 24 hr after plating. The drug and medium were changed every day. The effect of 5-FUra on cell number was determined 3 days after treatment; the effect of x-irradiation was determined 4 days after irradiation. * Shown as mean + SD (n > 6).
L-ascorbate completely prevented the cytotoxic effects of DTIC and partially (about 50%) prevented the effect of methotrexate (Table 5) .
Effect of Catalase. Na L-ascorbate, yg/ml (11), it also has been postulated (10) Na butyrate + Na L-ascorbate 12 ± 3 NB cells (50,000 per dish) were plated in Falcon tissue culture dishes (60 mm). Sodium ascorbate was added immediately after the addition of drug at 24 hr after plating. The medium and drug were changed every day and the cell number was counted (hematocytometer) at 4 days after treatment.
* Shown as mean + SD (n 2 8).
Cell Biology: Prasad et al. NB cells (50,000 per dish) were plated in Falcon tissue culture dishes (60 mm). Sodium ascorbate was added immediately after the addition of drug at 24 hr after plating. The medium and drug were changed every day and the cell number was counted (hematocytometer) at 4 days after treatment. * Shown as mean + SD (n 2 8).
shown that tumor cells contain low peroxidase activity, but the catalase activity was not measured in these investigations. For example, myleoperoxidase, an enzyme present in high concentration in neutrophils, is defective in acute myeloid leukemia (15, 16) . A nondialyzable, heat-labile inhibitor of myeloperoxidase has been extracted from lymphocytes of leukemia spleen (17) . A complete deficiency of peroxidase in amniotic fluid of pregnant patients with carcinoma of cervix has been noted (18) . In addition to the mechanisms leading to an accumulation of H202, other mechanisms such as an inhibition of superoxide dismutase by sodium ascorbate, leading to an accumulation of free radicals, may account for the cytotoxic effect of this agent.
The potentiating effect of the combined treatment of NB cells with sodium ascorbate and 5-FUra is not due to a vitamin property of the former because the D form was equally effective. It is also not due to its reducing property because glutathione did not potentiate the effect of 5-FUra. This effect may be due to an intracellular accumulation of H202 or free radicals because the addition of catalase to the culture medium does not provide protection. Another possibility is that the potentiating effect of sodium ascorbate may be mediated by dehydroascorbate.
If the present results can be applicable in vivo, the combination of sodium ascorbate with some of the currently used therapeutic agents may help to improve the current management of metastatic NB and possibly other neoplasms by killing * Shown as mean ± SD (n = 6-9). Neuroblastoma cells (50,000 per dish) were plated in Falcon tissue culture dishes (60 mm). Sodium ascorbate was added immediately after the addition of drug 24 hr after plating. The medium and drug were changed every day and the cell number was counted at 4 days after treatment by a hematocytometer. * Shown as mean ± SD (n > 8).
only certain kinds of tumor cells without further aggravating the host's immune system. Such a regimen can also reduce the dose requirements of cytotoxic drugs without reducing their cell-killing effects. However, if sodium L-ascorbate is used indiscriminately the combined treatment may decrease the effectiveness of certain chemotherapeutic agents. For example, sodium ascorbate decreases the cytotoxic effect of methotrexate and DTIC on NB cells in culture. This is possibly due to inactivation of these drugs in vitro by sodium ascorbate. If such a phenomenon is also observed in vivo, a reduction in the sodium ascorbate level in the blood prior to the administration of methotrexate and DTIC may increase their effectiveness or may decrease the dosage of drugs for the same effect on tumor cells. The present study also points out the possibility that sodium ascorbate may modulate the effect of various pharmacological agents. 
